First-line tislelizumab plus chemotherapy demonstrated a median overall survival of 15.0 months versus 12.9 months…
Late-breaking ESMO data show 56.2% of patients with resectable NSCLC who received tislelizumab plus chemotherapy…
TAIPEI, Taiwan--(BUSINESS WIRE)--CyberLink Corp. (5203.TW), a pioneer in AI and facial recognition technologies, has achieved…
QINGDAO, China--(BUSINESS WIRE)--For Chinese companies, planning localization layout in the local market to quickly enter…
TOKYO--(BUSINESS WIRE)--#MOVINdow--ATL Global Solution LLC, headquartered in Shibuya, Tokyo, and led by CEO Taro Kaneko,…
MONTREAL--(BUSINESS WIRE)--WorkJam, the world’s leading digital frontline workplace, announced today that it has expanded its…
Five professional-grade projectors available in a range of price points feature stellar image quality, advanced…
SAN JOSE, Calif.--(BUSINESS WIRE)--#8021x--Genians, the industry pioneer in NAC-driven Zero Trust Network Access (ZTNA) solutions,…
VicOne joins Trend Micro’s Zero Day Initiative in staging first-of-its-kind contest offering cash and prizes…
DUBLIN--(BUSINESS WIRE)--The "Roofing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.…